Journal
CELL METABOLISM
Volume 20, Issue 5, Pages 856-869Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2014.08.001
Keywords
-
Categories
Funding
- Outgoing AIRC/Marie Curie Fellowship
- German Academy of Sciences Leopoldina [LPDS 2011-6]
- Long-Term EMBO Fellowship
- SNSF [310030B-138667, 31003A-140780, CSRII3-136201, 310030-143748]
- Canton of Zurich
- EU Ideas ERC program [AdG-322424]
- EPFL
- EU Ideas program [AdG-231138]
- NIH [R01AG043930]
- Velux Stiftung
- MRC [MC_UP_1002/1] Funding Source: UKRI
- Swiss National Science Foundation (SNF) [310030_143748] Funding Source: Swiss National Science Foundation (SNF)
- Medical Research Council [MC_UP_1002/1] Funding Source: researchfish
Ask authors/readers for more resources
Mitochondrial activity is controlled by proteins encoded by both nuclear and mitochondrial DNA. Here, we identify Sirt7 as a crucial regulator of mitochondrial homeostasis. Sirt7 deficiency in mice induces multisystemic mitochondrial dysfunction, which is reflected by increased blood lactate levels, reduced exercise performance, cardiac dysfunction, hepatic microvesicular steatosis, and age-related hearing loss. This link between SIRT7 and mitochondrial function is translatable in humans, where SIRT7 overexpression rescues the mitochondrial functional defect in fibroblasts with a mutation in NDUFSI. These wide-ranging effects of SIRT7 on mitochondrial homeostasis are the consequence of the deacetylation of distinct lysine residues located in the hetero- and homodimerization domains of GABP beta 1, a master regulator of nuclear-encoded mitochondrial genes. SIRT7-mediated deacetylation of GABP beta 1 facilitates complex formation with GABP alpha and the transcriptional activation of the GABP alpha/GABP beta heterotetramer. Altogether, these data suggest that SIRT7 is a dynamic nuclear regulator of mitochondrial function through its impact on GABP beta 1 function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available